View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/HRSA | RIN: 0906-AB07 | Publication ID: Spring 2014 |
Title: ●Allowable Uses of Program Income Within the National Hemophilia Program | |
Abstract: This proposed rule would modify the allowable uses of program income from the 340B Drug Pricing Program for the National Hemophilia Program's Regional Hemophilia Network grantees within the Maternal and Child Health Bureau. | |
Agency: Department of Health and Human Services(HHS) | Priority: Info./Admin./Other |
RIN Status: First time published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: Not Yet Determined (To search for a specific CFR, visit the Code of Federal Regulations.) | |
Legal Authority: Social Security Act, title V, sec 501(a)(2 and 3) 42 USC 701 |
Legal Deadline:
None |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Federalism: No | |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Kathryn McLaughlin Public Health Analyst Department of Health and Human Services Health Resources and Services Administration 5600 Fishers Lane, Rockville, MD 20857 Phone:301 443-6829 Email: kmclaughlin@hrsa.gov |